To investigate whether biglycan is functionally implicated in the regulation of cancer cell growth in vivo, we generated MDA-MB-231 cells stably expressing BGN (MDA-MB-231/BGN) under the control of a doxycycline-inducible promoter. This evidence concerns the gene BGN and cancer.